Pfizer and BioNTech say updated Covid-19 boosters show increased immune response against Omicron variant

Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine, the companies said Saturday.